Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
08
04
2023
medline:
3
7
2023
pubmed:
4
5
2023
entrez:
4
5
2023
Statut:
ppublish
Résumé
In severe renal hyperparathyroidism (RHPT), whether administrating Cinacalcet before total parathyroidectomy can reduce post-operative hypocalcemia remains unclear. We compared post-operative calcium kinetics between those who took Cinacalcet before surgery (Group I) and those who did not (Group II). Patients with severe RHPT (defined by PTH ≥ 100 pmol/L) who underwent total parathyroidectomy between 2012 and 2022 were analyzed. Standardized peri-operative protocol of calcium and vitamin D supplementation was followed. Blood tests were performed twice daily in the immediate post-operative period. Severe hypocalcemia was defined as serum albumin-adjusted calcium < 2.00 mmol/L. Among 159 patients who underwent parathyroidectomy, 82 patients were eligible for analysis (Group I, n = 27; Group II, n = 55). Demographics and PTH levels before Cinacalcet administration were comparable (Group I: 169 ± 49 pmol/L vs Group II: 154 ± 45, p = 0.209). Group I had significantly lower pre-operative PTH (77 ± 60 pmol/L vs 154 ± 45, p < 0.001), higher post-operative calcium (p < 0.05), and lower rate of severe hypocalcemia (33.3% vs 60.0%, p = 0.023). Longer duration of Cinacalcet use correlated with higher post-operative calcium levels (p < 0.05). Cinacalcet use for > 1 year resulted in fewer severe post-operative hypocalcemia than non-users (p = 0.022, OR 0.242, 95% CI 0.068-0.859). Higher pre-operative ALP independently correlated with severe post-operative hypocalcemia (OR 3.01, 95% CI 1.17-7.77, p = 0.022). In severe RHPT, Cinacalcet led to significant drop in pre-operative PTH, higher post-operative calcium levels, and less frequent severe hypocalcemia. Longer duration of Cinacalcet use correlated with higher post-operative calcium levels, and the use of Cinacalcet for > 1 year reduced severe post-operative hypocalcemia.
Sections du résumé
BACKGROUND
BACKGROUND
In severe renal hyperparathyroidism (RHPT), whether administrating Cinacalcet before total parathyroidectomy can reduce post-operative hypocalcemia remains unclear. We compared post-operative calcium kinetics between those who took Cinacalcet before surgery (Group I) and those who did not (Group II).
METHODS
METHODS
Patients with severe RHPT (defined by PTH ≥ 100 pmol/L) who underwent total parathyroidectomy between 2012 and 2022 were analyzed. Standardized peri-operative protocol of calcium and vitamin D supplementation was followed. Blood tests were performed twice daily in the immediate post-operative period. Severe hypocalcemia was defined as serum albumin-adjusted calcium < 2.00 mmol/L.
RESULTS
RESULTS
Among 159 patients who underwent parathyroidectomy, 82 patients were eligible for analysis (Group I, n = 27; Group II, n = 55). Demographics and PTH levels before Cinacalcet administration were comparable (Group I: 169 ± 49 pmol/L vs Group II: 154 ± 45, p = 0.209). Group I had significantly lower pre-operative PTH (77 ± 60 pmol/L vs 154 ± 45, p < 0.001), higher post-operative calcium (p < 0.05), and lower rate of severe hypocalcemia (33.3% vs 60.0%, p = 0.023). Longer duration of Cinacalcet use correlated with higher post-operative calcium levels (p < 0.05). Cinacalcet use for > 1 year resulted in fewer severe post-operative hypocalcemia than non-users (p = 0.022, OR 0.242, 95% CI 0.068-0.859). Higher pre-operative ALP independently correlated with severe post-operative hypocalcemia (OR 3.01, 95% CI 1.17-7.77, p = 0.022).
CONCLUSION
CONCLUSIONS
In severe RHPT, Cinacalcet led to significant drop in pre-operative PTH, higher post-operative calcium levels, and less frequent severe hypocalcemia. Longer duration of Cinacalcet use correlated with higher post-operative calcium levels, and the use of Cinacalcet for > 1 year reduced severe post-operative hypocalcemia.
Identifiants
pubmed: 37140608
doi: 10.1007/s00268-023-07030-4
pii: 10.1007/s00268-023-07030-4
doi:
Substances chimiques
Cinacalcet
UAZ6V7728S
Calcium
SY7Q814VUP
Parathyroid Hormone
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1986-1994Informations de copyright
© 2023. The Author(s) under exclusive licence to Société Internationale de Chirurgie.
Références
Almquist M, Isaksson E, Clyne N (2020) The treatment of renal hyperparathyroidism. Endocr Relat Cancer 27:R21–R34. https://doi.org/10.1530/ERC-19-0284
doi: 10.1530/ERC-19-0284
pubmed: 31693488
Yuen NK, Ananthakrishnan S, Campbell MJ (2016) Hyperparathyroidism of renal disease. Perm J 20(3):15–127. https://doi.org/10.7812/TPP/15-127
doi: 10.7812/TPP/15-127
pubmed: 27479950
pmcid: 4991918
Block GA, Martin KJ, de Francisco ALM et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525. https://doi.org/10.1056/NEJMoa031633
doi: 10.1056/NEJMoa031633
pubmed: 15071126
Goodman WG, Frazao JM, Goodkin DA et al (2000) A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 58:436–445. https://doi.org/10.1046/j.1523-1755.2000.00183.x
doi: 10.1046/j.1523-1755.2000.00183.x
pubmed: 10886592
Goodman WG, Hladik GA, Turner SA et al (2002) The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13:1017–1024. https://doi.org/10.1681/ASN.V1341017
doi: 10.1681/ASN.V1341017
pubmed: 11912261
Block GA, Bushinsky DA, Cheng S et al (2017) Effect of etelcalcetide vs Cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial. JAMA 317:156–164. https://doi.org/10.1001/jama.2016.19468
doi: 10.1001/jama.2016.19468
pubmed: 28097356
Gojaseni P, Pattarathitinan D, Chittinandana A (2017) Efficacy of low-dose Cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study. Int J Nephrol Renov Dis 10:47–53. https://doi.org/10.2147/IJNRD.S124844
doi: 10.2147/IJNRD.S124844
Susantitaphong P, Vadcharavivad S, Susomboon T et al (2019) The effectiveness of Cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism. Ren Fail 41:326–333. https://doi.org/10.1080/0886022X.2018.1562356
doi: 10.1080/0886022X.2018.1562356
pubmed: 31014177
pmcid: 6493313
Dream S, Kuo LE, Kuo JH et al (2022) The American Association of Endocrine Surgeons Guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism. Ann Surg 276(3):141–176
doi: 10.1097/SLA.0000000000005522
Eknoyan G, Levin A, Levin NW (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:1–201. https://doi.org/10.1016/S0272-6386(03)00905-3
doi: 10.1016/S0272-6386(03)00905-3
Goonewardene S (2016) Parathyroidectomies: pre and post Op usage of calcium supplementation and effect on calcium levels. Arch Renal Dis Manag. https://doi.org/10.17352/2455-5495.000007
doi: 10.17352/2455-5495.000007
Steinl GK, Kuo JH (2021) Surgical management of secondary hyperparathyroidism. Kidney Int Rep 6:254–264. https://doi.org/10.1016/j.ekir.2020.11.023
doi: 10.1016/j.ekir.2020.11.023
pubmed: 33615051
Unsal IO, Calapkulu M, Sencar ME et al (2020) Preoperative Vitamin D levels as a predictor of transient hypocalcemia and hypoparathyroidism after parathyroidectomy. Sci Rep 10:9895. https://doi.org/10.1038/s41598-020-66889-8
doi: 10.1038/s41598-020-66889-8
pubmed: 32555278
pmcid: 7303145
Ferreira D, Vilayur E, Gao M et al (2019) Calcitriol loading before total parathyroidectomy with autotransplant in patients with end-stage kidney disease: does it prevent postoperative hypocalcaemia? Intern Med J 49:886–893. https://doi.org/10.1111/imj.14209
doi: 10.1111/imj.14209
pubmed: 30552793
Alsafran S, Sherman SK, Dahdaleh FS et al (2019) Preoperative calcitriol reduces postoperative intravenous calcium requirements and length of stay in parathyroidectomy for renal-origin hyperparathyroidism. Surgery 165:151–157. https://doi.org/10.1016/j.surg.2018.03.029
doi: 10.1016/j.surg.2018.03.029
pubmed: 30413326
Baker D, Sevak S, Callahan RE et al (2019) Outcomes in patients with renal hyperparathyroidism requiring Cinacalcet pre-operatively followed by parathyroidectomy. Am J Surg 217:146–151. https://doi.org/10.1016/j.amjsurg.2018.06.016
doi: 10.1016/j.amjsurg.2018.06.016
pubmed: 29929906
Somnay YR, Weinlander E, Schneider DF et al (2014) The effect of Cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy. Surgery 156:1308–1314. https://doi.org/10.1016/j.surg.2014.08.003
doi: 10.1016/j.surg.2014.08.003
pubmed: 25456900
Sun X, Zhang X, Lu Y et al (2018) Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Sci Rep 8:7743. https://doi.org/10.1038/s41598-018-26142-9
doi: 10.1038/s41598-018-26142-9
pubmed: 29773914
pmcid: 5958068
Yang M, Zhang L, Huang L et al (2016) Factors predictive of critical value of hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. Ren Fail 38:1224–1227. https://doi.org/10.1080/0886022X.2016.1202731
doi: 10.1080/0886022X.2016.1202731
pubmed: 27359159
Evenepoel P, Shroff R (2018) Facing Cinacalcet-induced hypocalcemia: sit back and relax? Kidney Int 93:1275–1277. https://doi.org/10.1016/j.kint.2018.01.038
doi: 10.1016/j.kint.2018.01.038
pubmed: 29792272
Meyers MO, Russell CP, Ollila DW et al (2009) Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of Cinacalcet. Am Surg 75:843–847
doi: 10.1177/000313480907500918
pubmed: 19774959
Mogl MT, Skachko T, Dobrindt EM et al (2021) Surgery for renal hyperparathyroidism in the Era of Cinacalcet: a single-center experience. Scandinavian Journal of Surgery 110:66–72. https://doi.org/10.1177/1457496919897004
doi: 10.1177/1457496919897004
pubmed: 31906794
Wirowski D, Goretzki PE, Schwarz K, Lammers BJ (2013) Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism. Langenbecks Arch Surg 398:131–138. https://doi.org/10.1007/s00423-012-1005-x
doi: 10.1007/s00423-012-1005-x
pubmed: 23007384
Gong W, Lin Y, Xie Y et al (2021) Predictors of early postoperative hypocalcemia in patients with secondary hyperparathyroidism undergoing total parathyroidectomy. J Int Med Res 49:030006052110150. https://doi.org/10.1177/03000605211015018
doi: 10.1177/03000605211015018
Liu J, Huang Q, Yang M et al (2020) Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. J Int Med Res 48:030006051989750. https://doi.org/10.1177/0300060519897505
doi: 10.1177/0300060519897505
Tan PG, Ab. Hadi IS, Zahari Z et al (2020) Predictors of early postoperative hypocalcemia after total parathyroidectomy in renal hyperparathyroidism. Ann Surg Treat Res 98:1. https://doi.org/10.4174/astr.2020.98.1.1
doi: 10.4174/astr.2020.98.1.1
pubmed: 31909044
Ho L-Y, Wong P-N, Sin H-K et al (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18:12. https://doi.org/10.1186/s12882-016-0421-5
doi: 10.1186/s12882-016-0421-5
pubmed: 28073343
pmcid: 5223390
Torer N, Torun D, Torer N et al (2009) Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. Transpl Proc 41:3642–3646. https://doi.org/10.1016/j.transproceed.2009.06.207
doi: 10.1016/j.transproceed.2009.06.207